Benjamin F. McGraw III
CIK: 0001216994
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EVMN
Evommune, Inc.
Director
Discretionary Trading P&L
Holdings
About MCGRAW BENJAMIN F III
MCGRAW BENJAMIN F III (SEC CIK 0001216994) files insider reports with the SEC as Director of Evommune, Inc. (EVMN).
Signal8 holds 3 ownership filings by MCGRAW BENJAMIN F III (1 Form 3, 2 Form 4), filed between Nov 5, 2025 and Jun 3, 2026. Those filings report 2 transactions, from Nov 5, 2025 to Jun 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MCGRAW BENJAMIN F III's filings is in PALO ALTO, CA.
Recent filings by MCGRAW BENJAMIN F III
Other insiders filing for Evommune, Inc. (EVMN)
- Pena Luis C., President & CEO
- Carver Kyle, Chief Financial Officer
- KIRSCH ARTHUR S, Director
- Drew Janice Suzann, Chief of Dev. Operations
- Patel Jeegar Pravinkumar, Chief Scientific Officer
- Cohen David E, Director